NCT00719810 - Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Skin Structure InfectionsBacterial Skin DiseasesStaphylococcal Skin Infections

Interventions

DRUG

delafloxacin

300 mg intravenous every 12 hours

DRUG

delafloxacin

450 mg intravenous every 12 hours

DRUG

tigecycline

100 mg then 50 mg intravenous tigecycline every 12 hours

Trial Locations (14)

Physician Alliance Research Center, Anaheim

Quality of Life Medical Center, LLC, Hawaiian Gardens

Tri City Medical Center, Oceanside

Crest Clinical Trials, Santa Ana

Internal Medicine Associates of Lee County, Fort Myers

Joseph M. Still Research Foundation, Inc., Augusta

Southeast Regional Research Group, Columbus

Southeast Regional Research Group, Ludowici

Southeast Regional Research Group, Savannah

St. James Health Care, Butte

Riverside Methodist Hospital, Columbus

West Houston Clinical Research Services, Houston

Westbury Medical Clinic, Houston

Clinical Research Puerto Rico, Inc, San Juan